Fingerprint
Dive into the research topics of 'Cabazitaxel: A novel second-line treatment for metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cabazitaxel: A novel second-line treatment for metastatic castration-resistant prostate cancer
Channing J. Paller, Emmanuel S. Antonarakis
Research output: Contribution to journal › Review article › peer-review
147
Scopus
citations